Contact us to find out if we have the data you need. Having offices around the globe, we are open 24 hours a day, 5 days a week with multiple language support. Please visit our Contact page to see which office is open right now!

Abstract Overview Introduction Prevalence of diabetic renal disease is on the rise. Current treatment focuses on the management of hypertension and glycemic control, b more…

Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep more…

Abstract INTRODUCTION The key objective was to present a comprehensive analysis of the current diabetes market and its future direction to meet the unmet demands of diabetic c more…

This Frost & Sullivan research service titled Strategic Analysis of the Kenyan Diabetes Markets provides an overview of the Kenyan healthcare industry in the context of more…

This Frost & Sullivan research service titled Strategic Analysis of the South African Diabetes Markets provides an overview of the South African healthcare industry in the more…

Overview Introduction Datamonitor expects the antihypertensives market to reach almost $40 billion, across the seven major markets, by 2016. The growth will be driven by the u more…

Overview Introduction The restrictive, highly competitive antidyslipidemic market is going to become even further genericized, which will add to the challenges that drug more…

A worldwide epidemic of type 2 diabetes has been in progress since the mid-1980s, according to the World Health Organization. The worldwide number of diabetics was 30 million more…

This research service analyzes the market for diabetes in vitro diagnostics within the United States. This service covers market trends, technology trends, competitive more…

This new strategic report from Espicom puts the spotlight on current and future drugs that will be used in the treatment of Type I and Type II diabetes, providing industry and more…

The diabetes diagnostics market in South Korea is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The more…

The diabetes diagnostics market in Japan is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis more…

This research service covers the pharmaceutical industry development pipeline for diabetes mellitus in the United States, with 2005 as the base year. Included are both the more…

Research Overview This Frost & Sullivan research service titled Emerging Therapies in Diabetes provides in-depth information about the various commercial products and more…

The study revolves around the area of continuous glucose monitoring and discusses the drivers, restraints, challenges and market trends. The study attempts to forecast the more…

Overview Introduction Overview of innovative developmental agents exploring alternative methods of administering insulin. more…

Data-intensive research - An imperative for the serious player! more…

Overview Introduction The diabetes epidemic has contributed in the growth of the antidiabetics market the past few years. Since the prevalence of diabetes continues to increas more…

Diabetes is one of the largest therapeutic segments of global pharmaceutical sales and during the last 10 years it has grown by a compound average growth rate of nearly 20% more…

Research Overview This research service is available through our Pharmaceutical and Clinical Diagnostics Growth Partnership Services program. With this program you receive more…

The life-threatening complications of type 2 diabetes constitute a significant unmet medical need worldwide, particularly because the prevalence of type 2 diabetes has soared more…

Overview Introduction The antidyslipidemics market is driven by the statins, which account for 87% of it. However, as many statins are expected to face patent expiry in the co more…

Overview Introduction The socio-economic consequences of diabetes and its complications make it a major public health issue. Patients with diabetes have a 25% reduction in more…

Overview Introduction Datamonitor estimates that there are 267m people in the seven major markets with total cholesterol >200mg/dL which is set to rise to 287m in 2015. Des more…

Analysis includes the use of charts and graphs measuring product growth and trends within the marketplace. more…

Research Overview Diabetes Sees a Dramatic Explosion due to an Increasingly High Proportion of Overweight People According to a new publication by the World Health more…

Increasing Levels of Diabetes Awareness in Europe offer a Growing Market for Diabetes Diagnostic Monitoring Systems In line with global trends, diabetes has become a more…

This new Freedonia industry study, Diabetes Monitoring & Therapy provides historical US demand data (1993, 1998, 2003) and forecasts to 2008 and 2013 for diabetes products by more…

This report analyzes diabetes market dynamics and provides a country-by-country drug and brand analysis enabling you to assess product success/failure within US and European more…

Evaluation of patient potential for developmental antidiabetics over theperiod 2004-2012 more…

This market briefing analyzes the world markets for inhaled insulintechnologies and products. more…

The reports from the All in Japan series provide overview and concise up-to-date description of each product from a specific product or therapeutic category approved in Japan. more…

Scope of thid report is the review of therapeutic approaches to gestational diabetes mellitus and pre-existing diabetes during pregnancy to protect the health of mother & baby more…

Scope of this report is determination of the prevalence of metabolic syndrome and its component conditions more…

Datamonitor believes that there will be a shift towards earlier initiation of insulin in the future, along with increased uptake, following the introduction of non-injected more…

With millions of diabetes patients suffering from neuropathic pain worldwide and no treatments yet approved for this indication in the US, the diabetic neuropathic pain (DNP) more…

It also provides market drivers, restraints, challenges, and strategic recommendations to overcome the challenges. The study is segmented into markets for injectable insulin, more…

The demand for glucose self-monitoring devices has seen tremendous growth in recent years. Developing countries are rapidly emerging as important markets for these devices, more…

The report will look at the demographics of the aging United States population, the expected incidence and prevalence of Type II diabetes, and the United States markets for more…

The study, The U.S. Diabetes Glucose Monitoring Market?Forecasts and Competitor Analysis, examines all the major trends and issues affecting the diabetes monitoring device more…

The type 1 and type 2 diabetes mellitus population is projected to grow from 39.4m to 49.4m from 2003-2010. The 25.4% growth rate over this time period reflects both the more…

In addition to epidemiology of diabetes Type 1 and Type 2 in Germany, this market summary will examine the top line market numbers in each of the following segments in more…

In addition to epidemiology of diabetes Type 1 and Type 2 in Japan, this market summary will examine the top line market numbers in each of the following segments in Japan, more…

For each country, these profiles provide prevalence information on type 1 and type 2 diabetes; market size and growth for diabetes monitoring, insulin, and oral hypoglycemics; more…

In 2001, six diabetes drugs achieved sales at or near $1bn, underlining the importance of diabetes brands to the overall market performance and positioning of several more…

This Brief identifies the cardiovascular and diabetes blockbusters of the future, or drugs that are likely to achieve annual global sales greater than $1bn, from the drugs more…

In 2001, the 100 highest selling global drug brands included 18 CV drugs and five diabetes drugs, which generated sales of $41bn and accounted for 29.2% of the top selling more…

This report contains a comprehensive analysis of current and emerging diabetes products and technology as well as providing a forecast for how those products will perform more…

The number of people with diabetes has reached epidemic proportions, with the International Diabetes Federation currently stating that it is the fourth main cause of death in more…